共 36 条
- [33] Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host Disease after In Vivo T Cell-Depleted Unrelated Donor Hematopoietic Stem Cell Transplantation in Children BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (10) : 1388 - 1401
- [34] Higher Total Nucleated Cell Dose, but Not CD3+, 4+, 8+, or 34+Cell Dose, Is Associated with Better Overall and Progression-Free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (AlloPBHCT) with TBI-Based Conditioning Regimens BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S30 - S31
- [35] High CD3+and CD34+peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation ONCOTARGET, 2016, 7 (19) : 27255 - 27266
- [36] Comparable results of HLA identical sibling donor peripheral blood hematopoietic stem cell transplantation after reduced-intensity and high-dose TBI-based CD34+-positive cell selection myeloablative preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission: Results from a prospective study. BLOOD, 2006, 108 (11) : 849A - 849A